Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Roger Brüggemann and Quirijn de Mast.
Roger Brüggemann
Connection Strength
0.403
Quirijn de Mast
  1. Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals. Int J Antimicrob Agents. 2021 Mar; 57(3):106293.
    View in: PubMed
    Score: 0.232
  2. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19. J Infect Dis. 2021 04 23; 223(8):1322-1333.
    View in: PubMed
    Score: 0.059
  3. More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine. Int J Infect Dis. 2021 02; 103:402-403.
    View in: PubMed
    Score: 0.057
  4. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife. 2020 04 27; 9.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.